Last reviewed · How we verify

NCT04624438

Central and Peripheral Changes in Quadriceps Femoris Function After Different Types of Isometric Strength Training

Completed NA Last updated 10 November 2020
What this trial tests

NA trial testing Isometric training with electromyostimulation in Quadriceps Muscle Function in 52 participants. Completed in 15 June 2018.

Timeline
9 April 2018
Primary endpoint
15 June 2018
15 June 2018

Quick facts

Lead sponsorUniversity of Belgrade
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposebasic science
Enrollment52
Start date9 April 2018
Primary completion15 June 2018
Estimated completion15 June 2018
Sites1 location across Serbia

Drugs / interventions tested

Conditions studied

Sponsor

University of Belgrade

Who can join

Adults 19 to 30, any sex, with Quadriceps Muscle Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this investigation is to examine the effects of 6-week unilateral isometric training interventions over quadriceps femoris on maximal strength and RFD-SF parameters and cortical excitability. Isometric strength training involved either electromyostimulation, voluntary activation, or the combination of both. The second aim is to investigate the potential cross-over effect on a non-trained leg.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Quadriceps Muscle Function

Currently open trials in the same condition.

Other University of Belgrade trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04624438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing